Mechanism and therapeutic strategy of hepatic TM6SF2-deficient non-alcoholic fatty liver diseases via in vivo and in vitro experiments

BACKGROUND: The lack of effective pharmacotherapies for nonalcoholic fatty liver disease (NAFLD) is mainly attributed to insufficient research on its pathogenesis. The pathogenesis of TM6SF2-efficient NAFLD remains unclear, resulting in a lack of therapeutic strategies for TM6SF2-deficient patients....

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Zu-Yin, Wu, Gang, Qiu, Chen, Zhou, Zhi-Jie, Wang, Yu-Peng, Song, Guo-He, Xiao, Chao, Zhang, Xin, Deng, Gui-Long, Wang, Rui-Tao, Yang, Yu-Long, Wang, Xiao-Liang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Baishideng Publishing Group Inc 2022
Materias:
Basic Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9280743/
https://www.ncbi.nlm.nih.gov/pubmed/35978872
http://dx.doi.org/10.3748/wjg.v28.i25.2937

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9280743/
https://www.ncbi.nlm.nih.gov/pubmed/35978872
http://dx.doi.org/10.3748/wjg.v28.i25.2937

Ejemplares similares